Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation.

Source:http://linkedlifedata.com/resource/pubmed/id/14507660

Download in:

View as

General Info

PMID
14507660